BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19666666)

  • 1. Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
    Hörl WH
    Nephrol Dial Transplant; 2009 Nov; 24(11):3285-7. PubMed ID: 19666666
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acetylsalicylic acid versus coumarin derivatives in atrial fibrillation].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2336-40. PubMed ID: 11129967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit?
    Krüger T; Floege J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3284-5. PubMed ID: 19628646
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilemmas in the management of atrial fibrillation in chronic kidney disease.
    Reinecke H; Brand E; Mesters R; Schäbitz WR; Fisher M; Pavenstädt H; Breithardt G
    J Am Soc Nephrol; 2009 Apr; 20(4):705-11. PubMed ID: 19092127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarins and survival in incident dialysis patients.
    Knoll F; Sturm G; Lamina C; Zitt E; Lins F; Freistätter O; Kronenberg F; Lhotta K; Neyer U
    Nephrol Dial Transplant; 2012 Jan; 27(1):332-7. PubMed ID: 21771750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atrial fibrillation in dialysis patients].
    Vázquez Ruiz de Castroviejo E; Sánchez Perales MC
    Nefrologia; 2006; 26(1):16-24. PubMed ID: 16649422
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
    Eiser AR
    Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial fibrillation, stroke and anticoagulation.
    Roy D; Mukherjee S; Chakravarty A
    J Assoc Physicians India; 2002 Sep; 50():1153-8. PubMed ID: 12516699
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
    Yalamanchili V; Reilly RF
    Semin Dial; 2011; 24(4):387-8. PubMed ID: 21851395
    [No Abstract]   [Full Text] [Related]  

  • 14. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing stroke rates in patients with atrial fibrillation: how low can we go?
    Ezekowitz MD; Koti MJ; Fulton B
    Circulation; 2009 Sep; 120(13):1169-70. PubMed ID: 19752317
    [No Abstract]   [Full Text] [Related]  

  • 18. [NOAK in atrial fibrillation and renal failure].
    St
    MMW Fortschr Med; 2016 Mar; 158(4):16. PubMed ID: 27119860
    [No Abstract]   [Full Text] [Related]  

  • 19. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.